Sayın Meslektaşlarım

Derlediğim tedavi protokolümüzün temelini oluşturan review ve klinik çalışmaların özetlerine ulaşabilirsiniz.

Mikrofototerapi ( Targeted Phototherapy )

Photodermatol Photoimmunol Photomed. 2011 Apr;27(2):108-10. doi: 10.1111/j.1600-0781.2011.00566.x.
Targeted phototherapy in combination with drug therapy for segmental vitiligo.
Lee DY, Kim CR, Lee JH.

Source
Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. dylee@skku.edu
Abstract
According to the previous reports, segmental vitiligo usually shows a poor response to phototherapy. Here, we report two cases of recent onset segmental vitiligo that showed good or excellent response to targeted phototherapy in combination with drug therapy. These findings suggest that segmental vitiligo can be improved by combination therapy if its onset is recent. © 2011 John Wiley & Sons A/S.
PMID:
21392114

Photomed Laser Surg. 2010 Oct;28(5):679-84.
Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P, Klahan SO.

Source
Division of Dermatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. pravit@adsl.loxinfo.com
Abstract
OBJECTIVE:
The aim of this study was to compare the efficacy of targeted narrowband UVB phototherapy plus topical tetrahydrocurcuminoid with that of targeted narrowband UVB monotherapy for induction of repigmentation in vitiligo.
BACKGROUND DATA:
The 308-nm excimer laser and targeted narrowband UVB phototherapy have recently been shown to be effective in repigmenting vitiligo. Studies have suggested that the combination of the 308-nm excimer laser and various topical treatments is more effective than UV monotherapy in the treatment of vitiligo.
MATERIALS AND METHODS:
Ten subjects with focal or generalized vitiligo were enrolled in this study. Two similar lesions were treated with eithertargeted narrowband UVB plus topical tetrahydrocurcuminoid cream or targeted UVB alone. The UV treatments were carried out twice a week for 12 weeks. The degree of repigmentation, documented by monthly digital photography, was assessed by a blinded dermatologist.
RESULTS:
On completion of the study, statistically significant repigmentation, compared with baseline, occurred in both treatment groups. The overall degree of repigmentation was slightly better in the combination group at 8 and 12 weeks (p = 0.078 and 0.158 respectively). Adverse effects were minor and well tolerated.
CONCLUSION:
Targeted narrowband UVB phototherapy plus topical tetrahydrocurcuminoid cream was slightly more effective than targetednarrowband UVB monotherapy for vitiligo located in UV-sensitive areas. However, the differences in degrees of repigmentation did not reach statistically significant levels.
PMID:
20961233

Int J Dermatol. 2010 Mar;49(3):317-23.
Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.
Yang YS, Cho HR, Ryou JH, Lee MH.

Source
Department of Dermatology, School of Medicine, Kyunghee University, Seoul, Korea.
Abstract
BACKGROUND:
Various repigmentation patterns such as perifollicular, marginal, diffuse, and mixed configuration can occur in vitiligo. The aim of this study was to clinically assess the types of repigmentation patterns obtained with narrow-band ultraviolet B (NBUVB) phototherapy or targetedphototherapy using a 308 nm excimer laser and to reveal whether the repigmentation patterns have any relationship to the location of lesions, patient’s age, duration of lesions, or speed of improvement.
METHODS:
This study enrolled 51 patients who had effective responses as compared with baseline when treated with NBUVB alone and 52 patients who had effective responses as compared with baseline when treated with excimer laser alone. We evaluated the repigmentation patterns when the responses to treatments appeared.
RESULTS:
The most frequent repigmentation pattern was the perifollicular type in both groups treated with NBUVB (42.2%) or excimer laser (51.3%), followed by marginal, diffuse, and combined, in that order. There was no significant difference in the repigmentation pattern according to the location of lesions, patient’s age, or duration of lesions. The marginal pattern was predominant in both NBUVB and excimer laser-treated groups when excellent responses (more than 75% repigmentation achieved at 12 weeks) appeared.
CONCLUSIONS:
The repigmentation patterns according to location, age, duration of lesions, and speed of response showed similarities in both the NBUVB and excimer laser-treated groups.
PMID:
20465673